Dance-based exercise with personalized nutrition for obese breast cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, about 40 obese breast cancer survivors in remission will be assigned to either a 12-week dance-based exercise plus tailored nutrition plan or to standard lifestyle. Participants will attend three supervised dance sessions weekly, receive a nutrition plan based on resting metabolic rate, and provide blood and stool samples, fitness data, and quality-of-life surveys before and after the program. The study aims to see if the intervention reduces body fat and visceral adiposity and improves cardiorespiratory fitness, motor performance, gut microbiota, and overall well-being. Outcomes will be compared between the intervention and control groups to determine potential metabolic, physical, and microbiome-related benefits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of breast cancer disease
* At least one year after breast cancer treatment
* Must be able to swallow tablets
* Must be able to folow physical exercise training

Exclusion Criteria:

* Clinical diagnosis of Parkinson's disease
* Insulin dependent diabetes
* Infectious diseases within the past 2 months
* Use of antibiotics within the past 4 weeks before recruitment

Where it's running

• Comenius University in Bratislava, Faculty of physical education and sport
  Bratislava, Slovakia Recruiting

Study contacts

• Principal investigator: Viktor Bielik, PhD — Comenius University, Faculty of Physical Education and Sport
• Study coordinator: Libuša Nechalová, PhD
• Email: libusa.nechalova@uniba.sk
• Phone: +421940361656

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Optimal timing of antibody drug conjugate therapy for advanced HER2-negative breast cancer

  This trial tests whether giving an antibody drug conjugate before chemotherapy is better or worse than the opposite sequence in women with advanced HER2-negative breast cancer who have progressed after first-line therapy.

  Recruiting Phase 2 Liaoning Cancer Hospital & Institute · Shenyang, Liaoning · NCT07657130

• Auricular Laser Acupuncture for Sleep in Breast Cancer Patients

  This trial tests whether active auricular laser acupuncture can improve sleep in women with breast cancer and insomnia compared with a sham laser.

  Recruiting Chung Shan Medical University · Taichung · NCT07547423

• Educational video series for women in breast cancer treatment

  This study tests whether access to an online sexual health video series helps women with newly diagnosed breast cancer communicate with their providers and access sexual-health services compared to usual care.

  Recruiting at 4 sites University of Colorado, Denver · Aurora, Colorado and 3 other locations · NCT07434817

• Auricular Acupressure for Perioperative Anxiety and Pain in Breast Cancer Surgery

  This randomized, single‑center trial tests whether NADA ear acupressure can reduce anxiety and pain around surgery for women with newly diagnosed breast cancer.

  Recruiting Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Stuttgart · NCT07423039

• Dextrose injections to loosen chest wall and armpit tightness after breast cancer

  This will try ultrasound-guided dextrose injections to relieve persistent chest wall and armpit tightness and improve arm function in women who had breast cancer and did not improve with physical therapy.

  Recruiting Taichung Veterans General Hospital · Taichung, Taiwan · NCT07378319

• Vitamin K, d‑chiro‑inositol and α‑lactalbumin for protecting bones during breast cancer hormone therapy

  This will test whether adding vitamin K, d‑chiro‑inositol and α‑lactalbumin to calcium and vitamin D better protects bone health in women on hormone therapy for breast cancer.

  Recruiting Regina Elena Cancer Institute · Latina, Italy and 1 other locations · NCT07256769

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.